Barnett Releases IND Submissions: A Primer

Barnett Releases IND Submissions: A Primer

Barnett International, a division of Cambridge Healthtech Institute, has announced the release of IND Submissions: A Primer, an in-depth guide to writing, editing, tracking, and submitting the original IND and applicable IND amendments. IND Submissions: A Primer is the only comprehensive IND manual of its kind.

Needham, MA (PRWEB) February 25, 2009 -- IND Submissions: A Primer provides a "hands-on" approach that teaches regulatory professionals - novice and veteran alike - to work with the regulations, guidance documents, content templates, contributing authors, and style guides necessary to write an IND. The book's writing tips show regulatory professionals how to produce a range of U.S. drug and biologics submissions that comply with the requirements and are also clear to read. Included with the book is a CD filled with electronic examples.

The 600-page, spiral-bound, hardcover book is easy to use, providing step-by-step instructions on how to plan, write, and submit regulatory documents. Each chapter (62 in total) is divided by easy-to-read tabs.

IND Submissions: A Primer is the ideal resource for new professionals entering the field, a useful training guide, and a valuable reference for the experienced professional. This comprehensive "how-to" guide contains:

•    Regulations and guidance document references

•    Overview and background of why the submission is required

•    Structure of the submission itself

•    Details on who should contribute to the submission

•    Where to pull, re-use, or start as a basis for information needed in a submission

•    Tips and lessons learned from the author's experience

•    Different perspectives on how a submission can be approached

•    Applicable FDA Form 1571 information for each submission

•    Paper publishing tips

•    Electronic CTD publishing sections for each submission, where applicable

•    Real life examples taken from the press and approved NDAs when available

•    Electronic examples and content templates to utilize so that an RA professional can begin immediately working on a submission

IND Submissions: A Primer is available for $295 per copy by calling 800-856-2556, or by ordering online at www.barnettinternational.com. Estimated shipping date is February 27, 2009.

About the author:

IND Submissions: A Primer was written by Meredith Brown-Tuttle, RAC, a regulatory consultant whose background incorporates all aspects of drug, device, and biologics development including clinical research, data management, medical writing, and regulatory affairs. She served for six years on the Board of Editors for the Regulatory Affairs Professional Society's journal, "Focus," and has published numerous articles, edited books and book chapters, and presented at professional meetings on a variety of clinical research and regulatory topics. Ms. Brown-Tuttle also teaches about regulatory submissions, intelligence, strategy, and agency interactions for the Regulatory Affairs Certificate program at UC Santa Cruz.

About Cambridge Healthtech Institute

Cambridge Healthtech Institute (CHI) is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations. CHI's portfolio of products includes Cambridge Healthtech Institute Conferences, Insight Pharma Reports, Cambridge Marketing Consultants, Cambridge Meeting Planners and Cambridge Healthtech's Media Group, which includes numerous e-newsletters as well as Bio-IT World magazine.

Founded in 1992, Cambridge Healthtech Institute strives to develop quality information sources that provide valuable new insights and competing points of view while offering balanced coverage of the latest developments. Basic research related to commercial implications is covered, with heavy emphasis placed on end-user insights into new products and technology as well as coverage on the strategy behind the business.

About Barnett International

Founded in 1979, Barnett International is widely recognized for its superior consulting services and its targeted education and training programs. Barnett helps clients get the most out of their research and development dollars by managing change effectively, improving organizational performance, and enhancing staff knowledge. The Barnett approach is a unique combination of strategy development and practical, hands-on implementation. The "Barnett Difference" is evident in our deep understanding of the clinical research process and in the rapid and tangible performance improvements we deliver.

We help pharmaceutical, biotechnology and medical device companies maximize the speed and quality of their product development efforts. With an international presence and with many staff members working from the client site for increased benefits, Barnett is able to apply a global expertise to its projects.

Our services include educational programs and products and consulting.

The source of our expertise:

•    Exclusively focused on the pharmaceutical/biopharmaceutical industry for more than 20 years

•    A team of talented professionals (150+) with deep-rooted industry insight and expertise

•    An in-depth understanding of different cultures and unique organizations

•    Experience working with major pharmaceutical companies around the world

•    Global resources with offices in the US and Europe

Media Contact:

Barnett International

Kate Bliss

Marketing Communications Manager

781-972-5435

###

Contact Information Tracey Fielding

7814-972-5429

American TeleCare, Inc. (ATI) Appoints Michael A. Brodeur as Chief Financial Officer

American TeleCare, Inc. (ATI) Appoints Michael A. Brodeur as Chief Financial Officer

American TeleCare, the Leader in Technology-Enabled Telehealth Solutions, Adds Accomplished Financial Executive to its Senior Management Team

Minneapolis (PRWEB) February 25, 2009 -- American TeleCare, Inc. (ATI) announced that Michael A. Brodeur has joined the company as its chief financial officer. ATI is the leader in the development and application of video-based telehealth solutions to advance patient care.

"Mike is a seasoned executive with more than 25 years of high-level financial management experience in the health care, medical device, biotechnology and clinical laboratory industries," said Randy Moore, M.D., M.B.A., chairman and chief executive officer, American TeleCare (ATI). "He brings ATI exceptional expertise in corporate finance, business development and the capital markets."

"With solutions that combine telecommunications technology with unmatched clinical functionality, ATI is at the forefront of the telehealth industry," said Brodeur. "Managing the costs of caring for patients with complex, chronic conditions is a fundamental challenge in health system reform. ATI is positioned to lead the way to establish new models of telehealth-supported care that connect high-risk patients to essential clinical expertise."

Immediately before joining ATI, Brodeur was the chief financial officer of Medical CV, Inc. (NASDAQ:MDCV), developer and manufacturer of laser-based surgical devices. He has also served as CFO of McKesson Medical Management (a $500 million pharmacy outsource provider to hospitals) and Meris Laboratories, Inc. (a $50 million clinical laboratory testing company). He previously held other senior financial leadership positions with EPS Solutions Corporation and WellPoint Health Networks, Inc., now WellPoint, Inc. (NYSE:WLP), which today is the nation's largest health insurer by member numbers. Brodeur was a managing partner at Prairieview CFO Partners, LLP, a CFO services firm for public and pre-IPO emerging and middle-market businesses. And as senior partner at Tatum CFO Partners, LLP, another national CFO services firm, he served as CFO of Molecular Diagnostics, Inc., now CytoCore, Inc. (OTCBB:CYTO) and Aastrom Biosciences, Inc. (NASDAQ:ASTM).

Brodeur is a certified public accountant who began his career at Ernst & Young. He earned a bachelor's of science degree in business administration and accountancy at California State University, Long Beach, Calif.

About American TeleCare, Inc. (ATI)

Founded in 1993, American TeleCare (ATI) is the pioneer of intelligent monitoring and video-based telehealth technology. With proven experience in clinical process re-engineering, ATI works with leading healthcare organizations to put their patients at the center of care teams and supports them with best-in-class solutions. ATI systems connect continuous healing relationships and deliver essential information for clinical and self care. Ongoing monitoring and constant care of patients at home keeps them connected to clinical expertise and may help prevent acute events. The results: 100-200 percent increases in provider productivity and 65-95 percent reductions in emergency room and inpatient costs - achieved as care teams help physicians watch over, improve and maintain their patients' health. For more information, visit www.americantelecare.com. Then call 800-323-6667.

NOTE: American TeleCare will exhibit at the American Telemedicine Association (ATA) Annual International Meeting & Exposition, which will be held on April 26-28, 2009 at the Rio All-Suites Hotel and Casino, Las Vegas, Nev. American TeleCare will be at booth #300.

###

Contact Information DAVID AQUILINA

American TeleCare, Inc. (ATI)

http://www.americantelecare.com

612.922.5551

Stemedica Advances its Certification to Become a Licensed Manufacturer of Adult Stem Cells for U.S. Based Clinical Trials

Stemedica Advances its Certification to Become a Licensed Manufacturer of Adult Stem Cells for U.S. Based Clinical Trials

Stemedica Cell Technologies, Inc. announced today that it has filed with the Food and Drug Branch of the State of California's Department of Public Health for certification as a licensed manufacturer of adult stem cells for U.S.-based Phase I and Phase II Clinical Trials.

San Diego, CA (PRWEB) February 25, 2009 -- Stemedica Cell Technologies (http://www.stemedica.com), Inc. ("Stemedica") announced today that it has filed with the Food and Drug Branch of the State of California's Department of Public Health for certification as a licensed manufacturer of adult stem cells for U.S.-based Phase I and Phase II Clinical Trials. Readiness for manufacture includes obtaining a California Drug Manufacturing License for the Stemedica facility in San Diego, California.

"Completion of this certification will allow us to manufacture stem cells under contract for clinical trials for Stemedica as well as for other companies and research centers in California and across the United States. This marks a significant milestone along the journey toward the future availability of stem cell treatment for patients who so urgently need it," said Dr. Maynard Howe, Vice Chairman and CEO at Stemedica.

To prepare for inspection, Stemedica fully reconstructed its facility according to FDA requirements, which had previously focused on research and development. Stemedica's manufacturing facility now includes a fully compliant manufacturing wing with entry-level gowning rooms, two ISO class 8 sterile gowning suites, an ISO Class 7 Manufacturing Clean Room, an ISO Class 7 Processing Clean Room, a Good Manufacturing Process compliant materials warehouse and a controlled-access Quality Control testing laboratory.

"As soon as Stemedica secures its license from the State of California's Department of Public Health, we plan on filing for one or more IND's (Investigative New Drug) for specific indications with the FDA using our proprietary technology. The final major step by the Food and Drug Branch within the Department of Public Health is an in-depth, in-person inspection by their personnel. We're particularly proud of the fact that we are ready for, and capable of, seeking licensing in California, which has exceptionally stringent standards," said Dr. Alex Kharazi, Vice President, Research & Manufacturing at Stemedica.

"Becoming a Licensed Manufacturer of clinical grade adult stem cells is a significant scientific and medical step forward for the Company," said Dr. Nikolai Tankovich, Stemedica's President and Chief Medical Officer. "Securing this status will allow us to become a primary CMO (Contract Manufacturing Organization) for other for-profit companies and the many research organizations interested in advancing stem cell research through clinical application. Additionally, achieving this regulatory status within the manufacturing world will provide Stemedica with the foundation to advance its own Phase I and Phase II Clinical Studies once approved by the FDA."

About Stemedica Technologies, Inc.

Stemedica Cell Technologies Inc. (www.stemedica.com (http://www.stemedica.com)) is a specialty biopharmaceutical company that is committed to the development and manufacture of best-in-class adult stem cells for use by approved research institutions and hospitals for pre-clinical and clinical studies. Within the United States, the Company is currently developing regulatory pathways for stroke, traumatic brain injury and wound repair. Outside the United States, Stemedica provides its adult stem cells to hospitals and research centers that are conducting studies under protocols approved by the appropriate regulatory agencies. These studies are focused on the treatment of neurodegenerative disease, sight restoration and wound repair. Stemedica is based in San Diego, California.

Media Contact for Stemedica: Dave McGuigan -- dmcguigan (at) stemedica.com.

###

Contact Information Dave McGuigan

Stemedica Cell Technologies Inc

http://www.stemedica.com

+1 858 658 0910

Paving the Way for Peace in the Middle East with Mind-Body Skills

Paving the Way for Peace in the Middle East with Mind-Body Skills

Truce talks are gridlocked, but this mission to provide trauma relief to both sides of the conflict goes forward. Dr. James S. Gordon and his international team plans a training of health and mental health professionals in both Israel and Gaza--the only program of its kind working in both Israel and Gaza. After arriving February 28th, 2009. With The Center for Mind-Body Medicine's groundbreaking model which teaches self-care techniques (such as meditation, guided imagery, biofeedback, and yoga, as well as self-expression in words, drawing, and movement, all in a supportive small group), Dr. Gordon and his team will help heal the wounds of war and bring relief to those suffering following the devastating siege on Gaza.

Washington, D.C., Tel Aviv, and Gaza (PRWEB) February 23, 2009 -- As truce talks drag on between Israel and Gaza, James S. Gordon, M.D., the distinguished psychiatrist who leads the Washington D.C.-based Center for Mind-Body Medicine (http://www.cmbm.org), will on March 4, 2009 lead an international team of Christian, Muslim, and Jewish mental health professionals into Gaza in a groundbreaking effort to relieve population-wide psychological trauma in that war-devastated Israeli-occupied territory. The team will arrive in Israel February 28, 2009 and make their way to a border crossing.

For the last seven years, Dr. Gordon and his CMBM team have been working intensively with the traumatized population in Gaza and Israel separately and jointly -- they are the only organization doing so. During this time, they've trained 300 Israeli professionals and 90 in Gaza to develop comprehensive, scientifically based programs that are effectively treating widespread post traumatic stress disorder, major depression, anxiety, violence, and despair.

CMBM's pioneering program, which recently received a research award from the US Department of Defense, combines such mind-body techniques as meditation, guided imagery, biofeedback, and yoga with self-expression in words, drawings, and movement in a supportive small group setting.

CMBM's program is a powerful force for peace for those living in Gaza. Before the recent Israeli invasion, CMBM's Gaza team, which has treated 15-20,000 children and adults, was providing up to 75 ten-week long mind-body groups every three months. In the aftermath of the devastation, the number of groups has tripled. The CMBM approach is currently also being offered to hundreds of families that lost members in the conflict, to orphaned children, mothers with 'failure to thrive' infants, and depressed, suicidal, and violent children and adults.

A wealth of data supports and informs CMBM's unique, highly effective model, which has been used to help traumatized populations in postwar Kosovo, post-Katrina New Orleans, as well as Israel and Gaza, and is now being implemented on an increasingly large scale with US military returning from Iraq and Afghanistan and their families.

As Dr. Gordon says, "The CMBM model is welcomed by people of all ages and races around the world because it is educational, non-stigmatizing, and demonstrably beneficial. It can be easily taught and can be used by all people of all ages on their own." Dr. Gordon describes this groundbreaking approach in his newest book Unstuck: Your Guide to the Seven-Stage Journey Out of Depression (Penguin Press; June 2008).

The results of CMBM's program are astonishing. A randomized controlled trial (RCT) on the use of the model with war-traumatized children in Kosovo -- the first RCT of any intervention with war-traumatized children -- was published in the prestigious Journal of Clinical Psychiatry in 2008; it showed an 80% decrease in symptoms following 12 sessions of mind-body skills groups. Also, data collected on the first 500 children and 600 adults in the CMBM Gaza program revealed significant decreases in symptoms of PTSD and depression and anger and increased hopefulness in those who participated in CMBM groups, gains which were largely maintained even during the ongoing siege of Gaza at six months' follow-up.

After four days working with the CMBM faculty in Israel and visiting with people affected by the Palestinian shelling in Sderot and Ashkelon, Dr. Gordon and his team will enter Gaza. During the first several days, they will visit with some of the thousands who have sought out CMBM-trained counselors to help them deal with the loss of family members and friends. During the following five days, Dr. Gordon and his colleagues will supervise the 15-member CMBM Gaza leadership team as they prepare 150 more of the most committed mental health professionals, including school psychologists and school counselors, to offer CMBM's program to Gaza's devastated children and their families.

Journalists are invited to accompany Dr. Gordon as he meets with CMBM's Israeli staff prior to entering Gaza and visits Sderot, and as the team interviews individuals and families throughout Gaza. There will be opportunities for interviews with Dr. Gordon and his Palestinian leadership team, traumatized families who have been aided, as well as the possibility to observe the training program. A short article on Dr. Gordon's work in Gaza (http://www.nytimes.com/2009/01/13/health/views/13case.html?ref=health) which appeared in the New York Times.

Dr. Gordon is a dynamic public speaker with a wealth of personal stories of children and adults he has helped find healing in the midst of loss and despair. A respected and world-renowned expert in mind-body medicine, he can bring the human aspects of this story to life in any medium -- radio, television, or print -- with a warm, knowledgeable voice and his wealth of experience. He is available for immediate comment and interview.

###

Contact Information Dr. Gordon EA

The Center for Mind-Body Medicine

http://www.cmbm.org

202-537-6837

Physicians Wellness Network Offers Online Laboratory Testing Services On Google Health

Physicians Wellness Network Offers Online Laboratory Testing Services On Google Health

webLAB™ ensures medical and legal compliance for consumer-selected lab tests

Jackson, Wyo. -- Physicians Wellness Network (PWN), the developer of webLAB, the first online consumer portal that connects consumers to laboratory testing services in a medically and legally compliant manner, today announced its integration with Google Health™, http://www.Google.com/Health

Consumers no longer need to go through the lengthy and often expensive process of scheduling multiple doctor appointments with several co-pays to get basic wellness tests such as a heart risk assessment. Instead they can select up to four basic lab tests online, starting at $54.95, using the webLAB wizard located in the Google Health Services Directory. The tests consumers order are conducted in a manner that fully complies with state and federal regulations. In addition, test results are delivered within a few days and can be stored in the consumer's Google Health account.

"webLAB makes it safe, easy and affordable for people to directly order lab tests online, then store and track the results electronically on Google Health," said John Eastman, director of business development for PWN. "With President Obama calling for a national system of electronic health records within five years, webLAB's integration with Google Health will provide momentum toward this initiative."

Google Health allows consumers to store and manage their medical records online, in one central place for free. Consumers can build online health profiles, import medical records and connect to online health services such as webLAB.

After a consumer selects one of four lab tests using webLAB on Google Health, a PWN physician provides prescriptive authority for the test to be conducted. The consumer then has their blood sample drawn at a local lab and a result is produced. A PWN physician reviews and releases the result to the consumer within a few days so that it can be imported into the consumer's Google Health account. A PWN representative follows up with the consumer in the event a critical value is presented in the result.

PWN offers four basic wellness tests with webLAB: Diabetes Risk Assessment; General Wellness; Heart Risk Assessment; and, Prostate Cancer Risk Assessment.

About Physicians Wellness Network

Physicians Wellness Network is the leading provider of compliance services for online wellness screening tests. Through a trusted national network of 250 credentialed physicians dedicated to connecting consumers with their own health information, PWN delivers what no one else in the industry can--fully compliant, private blood testing for consumers in every state. The network's unique, online data system--webLAB™--connects health consumers with laboratory testing and accurate results in a private and secure environment.

PWN was founded in 2001 and is a subsidiary of DocTalk, Inc. For more information, call 888-362-4321 or visit www.physicianswellnessnetwork.com.

# # #

Contact Information Suzanne Fedoruk

For Physicians Wellness Network

http://www.physicianswellnessnetwork.com

612-861-7807

Carestream Molecular Imaging Releases Western Blot Kits For Added Convenience, Better Performance

Carestream Molecular Imaging Releases Western Blot Kits For Added Convenience, Better Performance

Carestream Molecular Imaging today released convenient, cost-effective kits for performing western blots -- a popular analytical technique used to detect proteins.

New Haven, CT (Vocus) February 23, 2009 -- Carestream Molecular Imaging, a division of Carestream Health, Inc., today released convenient, cost-effective kits for performing western blots (http://mistore.carestreamhealth.com) -- a popular analytical technique used to detect proteins. KODAK X-SIGHT Western Kits provide industry-leading components and step-by-step protocols designed to deliver peak performance from X-SIGHT Nanosphere Conjugates in western blots.

"The X-SIGHT Nanosphere Conjugates, when used with the components supplied in the Western Kit, outperformed our current western blot method," said Kevin McCarthy, Ph.D., Professor, Department of Pathology, LSU Health Sciences Center-Shreveport. "The whole process was faster, easier and the signal obtained was immediate, more stable and brighter -- with less background noise."

KODAK X-SIGHT Western Kits are built on X-SIGHT Nanospheres (http://mistore.carestreamhealth.com), which are available in four distinct wavelengths including three in the near-IR range. The kits are offered in several different wavelength combinations that include up to three X-SIGHT Nanosphere Conjugates, making them ideal for multiplex applications (http://mistore.carestreamhealth.com). Each kit is optimized for 10 blots and includes best-in-class membranes and buffers to achieve high signal-to-noise ratios. A separate Accessory Kit is also available for use with any of the X-SIGHT Nanosphere Conjugates or any other commercially available fluorescently-labeled secondary antibody conjugate (nanoparticle or dye).

The new kit delivers added productivity and can reduce costs when compared with purchasing each component separately or in larger quantities than may be necessary. Components suppliers include Fisher BioReagents (Fairlawn, NJ) part of Thermo Fisher Scientific and Millipore Corporation (Billerica, Mass.).

The kits are available worldwide. U.S. customers can place orders directly or through channel partners. For more information, go to http://mistore.carestreamhealth.com.

About Carestream Molecular Imaging

Carestream Molecular Imaging group, a division of Carestream Health, Inc., develops and markets high performance digital imaging systems, imaging agents, film and accessories under the KODAK brand for the life science research and drug discovery/development market segments. For more information, visit mi.carestreamhealth.com or call 1-877-747-4357, express code 7. Outside of the United States, call 1-203-786-5657.

About Carestream Health, Inc.

Carestream Health, Inc., is a leading provider of dental and medical imaging systems and healthcare IT solutions; molecular imaging systems for the life science research and drug discovery/development market segments; and x-ray film and digital x-ray products for the non-destructive testing market. Headquartered in Rochester, N.Y., and serving customers in more than 150 countries, Carestream Health is an independent company operating within the family of companies owned by Onex Corporation (TSX: OCX.TO) of Toronto, Canada. For more information about Carestream Health, contact your Carestream Health representative or visit www.carestreamhealth.com.

KODAK is a trademark of Kodak used under license.

X-SIGHT is a trademark of Carestream Health.

###

Contact Information Jim Barillo

Carestream Health, Inc.

http://mistore.carestreamhealth.com

585-627-6440

Robette Brooks

CCS PR

303-699-8861

Reprints Desk Named to "KMWorld 100 Companies that Matter in Knowledge Management" List

Reprints Desk Named to "KMWorld 100 Companies that Matter in Knowledge Management" List

Reprints Desk, Inc., the content workflow company, today announced that the company has been named as one of "KMWorld's 100 Companies that Matter in Knowledge Management" by KMWorld Magazine.

Los Angeles, Calif. (PRWEB) February 23, 2009 -- Reprints Desk, Inc., the content workflow company (http://www.reprintsdesk.com/main/home.aspx), today announced that the company has been named as one of "KMWorld's 100 Companies that Matter in Knowledge Management" by KMWorld Magazine.

KMWorld's annual list, now in its eighth year, is compiled by knowledge management (KM) practitioners, theorists, analysts, vendors, and customers. Companies that have previously been named to the list include Google, Apple, Oracle, SAP, and EMC.

"Each company embodies as part of its culture agile and limber execution of its mission, embracing a spirit of both adaptability and innovation," said Hugh McKellar, KMWorld editor in chief.

In 2008, Reprints Desk achieved a number of accomplishments:

• Ranked first overall and in each category within the Document Delivery (http://www.reprintsdesk.com/main/docdel_overview.aspx) Best Practices and Vendor Scorecard Report published by Outsell, Inc.

• Served more than 50% of the world's top-50 pharmaceutical companies

• Launched eCTD Article Service (http://www.reprintsdesk.com/main/news.aspx) for regulatory submissions

• Established an office in Germany to support European sales

• Became a document supplier on FIZ Karlsruhe's full-text broker service FIZ AutoDoc

• Signed an agreement with the Copyright Clearance Center to integrate rights management from Rightsphere into the document delivery workflow

Reprints Desk is headquartered in Los Angeles, California, and was founded in 2006 by document delivery pioneer Peter Derycz. The company provides software services that simplify how healthcare companies and other research-oriented enterprises procure, manage, and share peerreviewed journal articles and other copyright-protected content.

About KMWorld

The leading information provider serving the Knowledge, Document and Content Management systems market, KMWorld informs more than 50,000 subscribers about the components and processes - and subsequent success stories - that together offer solutions for improving business performance. KMWorld is a publishing unit of Information Today, Inc.

About Reprints Desk ®

Reprints Desk, Inc. (www.reprintsdesk.com), is a content technology and services company that simplifies how healthcare companies and other enterprises procure, manage and share scientific journal articles and other copyright-protected content. The company's workflow solutions and end user tools help customers effectively use peer-reviewed literature in product promotions, regulatory submissions, and research. A channel supplier for more than 100 scientific, technical, and medical (STM) publishers, Reprints Desk currently serves more than half of the world's Top-50 pharmaceutical companies and earned the #1 ranking in the 2008 Document Delivery Vendor Scorecard by Outsell, Inc. Reprints Desk is a Derycz Scientific, Inc. (OTC: DYSC.PK) company. For more information about Reprints Desk, contact Ian Palmer at +1 (707) 658-1931.

Public and Media Relations Contacts:

Ian Palmer, Head of Marketing

Reprints Desk, Inc. | +1 707.658.1931

ipalmer @ reprintsdesk.com

# # #

Contact Information Ian Palmer

Reprints Desk

http://www.reprintsdesk.com

707.658.1931